Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 26:5:70.
doi: 10.3389/fmolb.2018.00070. eCollection 2018.

Precision Medicine for Neonatal Sepsis

Sherrianne Ng  1 , Tobias Strunk  2 , Pingping Jiang  3 , Tik Muk  3 , Per T Sangild  3 , Andrew Currie  1   2
Affiliations
Review

Precision Medicine for Neonatal Sepsis

Sherrianne Ng et al. Front Mol Biosci. .

Abstract

Neonatal sepsis remains a significant cause of morbidity and mortality especially in the preterm infant population. The ability to promptly and accurately diagnose neonatal sepsis based on clinical evaluation and laboratory blood tests remains challenging. Advances in high-throughput molecular technologies have increased investigations into the utility of transcriptomic, proteomic and metabolomic approaches as diagnostic tools for neonatal sepsis. A systems-level understanding of neonatal sepsis, obtained by using omics-based technologies (at the transcriptome, proteome or metabolome level), may lead to new diagnostic tools for neonatal sepsis. In particular, recent omic-based studies have identified distinct transcriptional signatures and metabolic or proteomic biomarkers associated with sepsis. Despite the emerging need for a systems biology approach, future studies have to address the challenges of integrating multi-omic data with laboratory and clinical meta-data in order to translate outcomes into precision medicine for neonatal sepsis. Omics-based analytical approaches may advance diagnostic tools for neonatal sepsis. More research is needed to validate the recent systems biology findings in order to integrate multi-dimensional data (clinical, laboratory and multi-omic) for future translation into precision medicine for neonatal sepsis. This review will discuss the possible applications of omics-based analyses for identification of new biomarkers and diagnostic signatures for neonatal sepsis, focusing on the immune-compromised preterm infant and considerations for clinical translation.

Keywords: diagnosis; infection; neonate; preterm infant; sepsis; systems biology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of current and future approaches for diagnosis of neonatal sepsis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alyass A., Turcotte M., Meyre D. (2015). From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med. Genomics 8:33. 10.1186/s12920-015-0108-y - DOI - PMC - PubMed
    1. Antonucci R., Pilloni M. D., Atzori L., Fanos V. (2012). Pharmaceutical research and metabolomics in the newborn. J. Matern. Fetal. Neonatal. Med. 25(Suppl. 5), 22–26. 10.3109/14767058.2012.714634 - DOI - PubMed
    1. Arboleya S., Sanchez B., Milani C., Duranti S., Solis G., Fernandez N., et al. . (2015). Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics. J. Pediatr. 166, 538–544. 10.1016/j.jpeds.2014.09.041 - DOI - PubMed
    1. Bateman S. L., Seed P. C. (2010). Procession to pediatric bacteremia and sepsis: covert operations and failures in diplomacy. Pediatrics 126, 137–150. 10.1542/peds.2009-3169 - DOI - PMC - PubMed
    1. Buchegger P., Sauer U., Toth-Szekely H., Preininger C. (2012). Miniaturized protein microarray with internal calibration as point-of-care device for diagnosis of neonatal sepsis. Sensors 12, 1494–1508. 10.3390/s120201494 - DOI - PMC - PubMed

LinkOut - more resources